tiprankstipranks
Advertisement
Advertisement

VYNE Stock Latest News

VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance
Company AnnouncementsVYNE Therapeutics Granted Nasdaq Extension to Regain Compliance
2M ago
8K
VYNE
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience
PremiumCompany Announcements
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience
3M ago
8K
VYNE
3 Penny Stocks to Watch Now, 12/18/25
PremiumMarket News
3 Penny Stocks to Watch Now, 12/18/25
5M ago
BEAT
VYNE
Hold Rating for VYNE Therapeutics Amid Strategic Shift and Clinical Uncertainty Following Yarrow Bioscience Merger
PremiumRatings
Hold Rating for VYNE Therapeutics Amid Strategic Shift and Clinical Uncertainty Following Yarrow Bioscience Merger
5M ago
VYNE
VYNE Therapeutics Announces Merger with Yarrow Bioscience
PremiumCompany Announcements
VYNE Therapeutics Announces Merger with Yarrow Bioscience
5M ago
8K
VYNE
VYNE Therapeutics, Yarrow Bioscience enter merger agreement
PremiumThe FlyVYNE Therapeutics, Yarrow Bioscience enter merger agreement
5M ago
VYNE
VYNE Therapeutics Approves Director Elections and Proposals
Premium
Company Announcements
VYNE Therapeutics Approves Director Elections and Proposals
5M ago
8K
VYNE
VYNE Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
VYNE Therapeutics Reports Q3 2025 Financial Results
6M ago
VYNE
VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year
PremiumThe Fly
VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year
6M ago
VYNE
VYNE Therapeutics Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
VYNE Therapeutics Faces Nasdaq Non-Compliance Notice
8M ago
8K
VYNE
VYNE Therapeutics Reports Q2 2025 Financials and Updates
PremiumCompany Announcements
VYNE Therapeutics Reports Q2 2025 Financials and Updates
9M ago
VYNE
VYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability
PremiumRatings
VYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability
9M ago
VYNE
VYNE Therapeutics Directors Resign Amid Financial Updates
PremiumCompany AnnouncementsVYNE Therapeutics Directors Resign Amid Financial Updates
9M ago
8K
VYNE
VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year
Premium
The Fly
VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year
9M ago
VYNE
VYNE Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VYNE Earnings this Week: How Will it Perform?
9M ago
VYNE
Watch Out! Analysts Have Recently Downgraded These Stocks
PremiumMarket News
Watch Out! Analysts Have Recently Downgraded These Stocks
9M ago
AMD
NEO
Why Is VYNE Therapeutics Stock (VYNE) Down 70% Today?
PremiumMarket News
Why Is VYNE Therapeutics Stock (VYNE) Down 70% Today?
9M ago
VYNE
VYNE Therapeutics downgraded to Neutral from Buy at BTIG
PremiumThe Fly
VYNE Therapeutics downgraded to Neutral from Buy at BTIG
9M ago
VYNE
VYNE Therapeutics: Buy Rating Supported by Promising VYN202 Prospects Amidst Challenges
PremiumRatings
VYNE Therapeutics: Buy Rating Supported by Promising VYN202 Prospects Amidst Challenges
9M ago
VYNE
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
9M ago
MO
QS
VYNE Therapeutics downgraded at H.C. Wainwright after vitiligo trial miss
Premium
The Fly
VYNE Therapeutics downgraded at H.C. Wainwright after vitiligo trial miss
9M ago
VYNE
VYNE Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
VYNE Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
9M ago
VYNE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >